Missing will reveal what, and when, he decides.
I find it interesting that a major topic of late has been postings telling readers just why Missling needs to release new Anavex 2-73 data or information. It is presumed by these posters that Missling is derelict in his management duties by failing to publically disclose all that he now knows about Anavex 2-73.
Personally, I have no such concerns. Unlike some, I don't presume to know "what's best for the company." I've never managed a pharmaceutic start-up (nor anything else but classrooms of hyper-active teenagers).
I have every confidence that Missling is following an internal plan for Anavex Life Sciences Corp. By many orders of magnitude (number of personally held AVXL shares), Missling has far more to lose than I, should his management of the company fail.
He knows exactly what the company might gain or lose by premature disclosure of new information. It will come to public light, with the best outcomes, in a proper time frame and form.
Again, insiders in both Anavex and any potential collaborating pharmaceuticals know what they need to know. Anavex science is unique, sound, effective, safe, and will eventually generate massive revenues for fiscal stakeholders of Anavex.
At no time will I be telling Missling how he needs to run the company. He and his team are exceptionally well-qualified --- by orders of magnitude better than any of us who post here.
Anavex, forward....
